Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.41 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.41 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | APEX1 | P27695 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28326417 | 0.91 | MEN1 (0.39) | POLBTXNRD1TXNRD3TXNRD2TDP1 | |
| SCHEMBL311328 | 0.89 | TXNRD1 (0.49) | POLBTXNRD1TXNRD3TXNRD2TDP1 | |
| SCHEMBL21359970 | 0.87 | POLB (0.42) | POLBTXNRD1TXNRD3TXNRD2TDP1 | |
| Morpholine SCHEMBL27607357 | 0.77 | POLB (0.41) | POLBTXNRD1TXNRD3TXNRD2TDP1 | |
| SCHEMBL29395442 | 0.74 | POLB (0.46) | POLBTXNRD1TXNRD3TXNRD2TDP1 | |
| Benzimidazole SCHEMBL7068655 | 0.72 | SMN1; SMN2 (0.45) | POLBTDP1KMT2AALDH1A1L3MBTL1 | |
| Nitric Acid SCHEMBL14695341 | 0.71 | CYP3A4 (0.39) | POLBTXNRD1TXNRD3TXNRD2TDP1 | |
| SCHEMBL5675915 | 0.70 | CLK1 (0.50) | POLBTDP1MEN1KMT2AALDH1A1 | |
| SCHEMBL28202812 | 0.70 | PARP1 (0.57) | POLBTXNRD1TXNRD3TXNRD2TDP1 | |
| SCHEMBL7247062 | 0.69 | KDM4E (0.51) | POLBTDP1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024136630-A1 | METHOD FOR SEQUENCE HOMOLOGY SEARCH OF NUCLEOTIDE DATABASE | 주식회사 씨젠 | 2024-06-27 | — | — | WO | claimed |
| EP-4293127-A2 | METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY | Seegene, Inc. (KR) | 2023-12-20 | — | — | EP | claimed |
| EP-4001428-B1 | METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY | SEEGENE INC (KR) | 2023-11-22 | — | — | EP | claimed |
| CN-110168103-B | Methods for reducing primer dimer formation and increasing amplification efficiency | SEEGENE株式会社 | 2023-09-08 | — | — | CN | claimed |
| CN-115341017-A | Kit and detection method for rapidly detecting gene variation based on lighted click connection probe | 中国人民解放军陆军特色医学中心 | 2022-11-15 | — | — | CN | claimed |
| EP-4001428-A1 | METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY | Seegene, Inc. (KR) | 2022-05-25 | — | — | EP | claimed |
| EP-3562958-B1 | METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY | SEEGENE INC (KR) | 2021-11-03 | — | — | EP | claimed |
| US-10870675-B2 | Process using dual specificity oligonucleotide and dual specificity oligonucleotide | SEEGENE, INC. (KR) | 2020-12-22 | — | — | US | claimed |
| EP-3562958-A1 | METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY | Seegene, Inc. (KR) | 2019-11-06 | — | — | EP | claimed |
| US-20190316193-A1 | METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY | SEEGENE, INC. (KR) | 2019-10-17 | — | — | US | claimed |
| WO-2006095941-A1 | PROCESSES USING DUAL SPECIFICITY OLIGONUCLEOTIDE AND DUAL SPECIFICITY OLIGONUCLEOTIDE | SEEGENE, INC. (KR) | 2006-09-14 | — | — | WO | claimed |
| WO-2005083120-A1 | METHOD FOR AMPLIFYING MEMBERS OF A GENE FAMILY | SEEGENE, INC. (KR) | 2005-09-09 | — | — | WO | claimed |
| WO-2005083121-A1 | METHOD FOR AMPLIFYING MEMBERS OF A GENE FAMILY | SEEGENE, INC. (KR) | 2005-09-09 | — | — | WO | claimed |
| US-20050164184-A1 | Hybridization portion control oligonucleotide and its uses | SEEGENE, INC. (KR) | 2005-07-28 | — | — | US | claimed |
| WO-2005045073-A1 | METHOD FOR AMPLIFYING UNKNOWN DNA SEQUENCE ADJACENT TO KNOWN SEQUENCE | SEEGENE, INC. (KR) | 2005-05-19 | — | — | WO | claimed |
| CN-1602361-A | Hybridization portion control oligonucleotide and use thereof | SEEGENE INC (KR) | 2005-03-30 | — | — | CN | claimed |
| CN-1578841-A | Annealing control primer and use of the same | VISION GENE CO LTD (KR) | 2005-02-09 | — | — | CN | claimed |
| EP-1448795-A1 | HYBRIDIZATION PORTION CONTROL OLIGONUCLEOTIDE AND ITS USES | Seegene, Inc. (KR) | 2004-08-25 | — | — | EP | claimed |
| US-20030175749-A1 | Annealing control primer and its uses | SEEGENE, INC. (KR) | 2003-09-18 | — | — | US | claimed |
| WO-2003050306-A1 | HYBRIDIZATION PORTION CONTROL OLIGONUCLEOTIDE AND ITS USES | SEEGENE, INC. (KR) | 2003-06-19 | — | — | WO | claimed |